News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Canada (BMY) Release: Quebec Leads the Way in Improving Access to Rheumatoid Arthritis Treatments



6/26/2007 10:32:43 AM

MONTREAL, June 26 /CNW Telbec/ - Quebec is the first province in Canada to add Orencia to its list of reimbursed medications to treat rheumatoid arthritis. Bristol-Myers Squibb Canada is happy to announce today that Orencia(R) (abatacept), the first in a new class of biologic agents for rheumatoid arthritis (RA) will be reimbursed by the Régime général d'assurance médicaments du Québec.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES